UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044541
Receipt number R000050886
Scientific Title Effectiveness of cell-free and concentrated ascites reinfusion therapy in the treatment of malignancy-related ascites: A systematic review and meta-analysis
Date of disclosure of the study information 2021/06/15
Last modified on 2021/11/30 14:04:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of cell-free and concentrated ascites reinfusion therapy in the treatment of malignancy-related ascites: A systematic review and meta-analysis

Acronym

Effectiveness of cell-free and concentrated ascites reinfusion therapy in the treatment of malignancy-related ascites: A systematic review and meta-analysis

Scientific Title

Effectiveness of cell-free and concentrated ascites reinfusion therapy in the treatment of malignancy-related ascites: A systematic review and meta-analysis

Scientific Title:Acronym

CART in malignant ascites

Region

Japan


Condition

Condition

malignancy-related ascites

Classification by specialty

Hematology and clinical oncology Nephrology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Identifying the effectiveness of cell-free and concentrated ascites reinfusion therapy in the treatment of malignancy-related ascites:

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Improved symptoms

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

malignancy-related ascites

Key exclusion criteria

Cirrhosis ascites

Target sample size



Research contact person

Name of lead principal investigator

1st name Hao
Middle name
Last name Chen

Organization

Teikyo University Hospital

Division name

Department of Oncology

Zip code

173-8606

Address

2-11-1 Kaga, Itahashi

TEL

03-3964-1211

Email

chinsmd@gmail.com


Public contact

Name of contact person

1st name Hao
Middle name
Last name Chen

Organization

Teikyo University Hospital

Division name

Department of Oncology

Zip code

173-8606

Address

2-11-1 Kaga, Itahashi

TEL

03-3964-1211

Homepage URL


Email

chinsmd@gmail.com


Sponsor or person

Institute

Teikyo University Hospital

Institute

Department

Personal name



Funding Source

Organization

Teikyo University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Teikyo University Hospital

Address

2-11-1 Kaga, Itahashi

Tel

03-3964-1211

Email

chinsmd@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 06 Month 15 Day

Date of IRB

2021 Year 06 Month 15 Day

Anticipated trial start date

2021 Year 06 Month 15 Day

Last follow-up date

2021 Year 07 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

not applicable


Management information

Registered date

2021 Year 06 Month 15 Day

Last modified on

2021 Year 11 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050886


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name